UBC was pleased to connect with so many industry colleagues at DIA 2019. We look forward to continuing the conversation on important clinical development and safety developments.
August 11, 20254 min read
UBC Launches New Pharmacovigilance Reporting Capabilities
UBC launches new RxLogix pharmacovigilance reporting platform to enhance drug safety capabilities with advanced aggregate reporting, real-time analytics, and reduced regulatory risk for biopharmaceutical companies.